Geode Capital Management, LLC Galecto, Inc. Transaction History

Geode Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$0.47 - $0.76 $2,726 - $4,408	5,801 Added 2.78%	214,134 $100,000
Q3 2023 Nov 13, 2023	BUY	$0.56 - $3.17 $8,199 - $46,415	14,642 Added 7.56%	208,333 $149,000
Q2 2023 Aug 11, 2023	BUY	$1.68 - $2.84 $142,364 - $240,664	84,741 Added 77.78%	193,691 $488,000
Q4 2022 Feb 13, 2023	BUY	$1.06 - $58.5 $2,982 - $164,619	2,814 Added 2.65%	108,950 $125,000
Q2 2022 Aug 12, 2022	BUY	$1.22 - $2.74 $10,920 - $24,525	8,951 Added 9.21%	106,136 $183,000
Q1 2022 May 13, 2022	BUY	$1.72 - $3.31 $1,804 - $3,472	1,049 Added 1.09%	97,185 $213,000
Q4 2021 Feb 11, 2022	BUY	$2.3 - $3.58 $52,485 - $81,695	22,820 Added 31.13%	96,136 $291,000
Q3 2021 Nov 12, 2021	SELL	$3.59 - $5.0 $5,040 - $7,020	-1,404 Reduced 1.88%	73,316 $263,000
Q2 2021 Aug 13, 2021	BUY	$4.63 - $8.0 $345,953 - $597,760	74,720 New	74,720 $378,000

21.2K

Ticker GLTO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,395,700
Market Cap $120M
Description
Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clini...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.